These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11454307)

  • 1. Treatment of murine leukaemia with x-rays and homologous bone marrow: II. 1957.
    Barnes DW; Loutit JF
    J Hematother Stem Cell Res; 2001 Jun; 10(3):325-34. PubMed ID: 11454307
    [No Abstract]   [Full Text] [Related]  

  • 2. The foundations of cellular therapy: Barnes and Loutit, 1957.
    English D; Klingemann HG
    J Hematother Stem Cell Res; 2001 Jun; 10(3):323-4. PubMed ID: 11454306
    [No Abstract]   [Full Text] [Related]  

  • 3. Allogeneic marrow engraftment following whole body irradiation in a patient with leukemia. 1970.
    Buckner CD; Epstein RB; Rudolph RH; Clift RA; Storb R; Thomas ED
    J Hematother Stem Cell Res; 2001 Apr; 10(2):201-8. PubMed ID: 11359667
    [No Abstract]   [Full Text] [Related]  

  • 4. Radiation sensitizing and radiation protective agents in experimental radiation therapy.
    Ambrus JL; Halpern J; Bardos T; Chmielwicz ZF; Klein E
    J Med; 1988; 19(5-6):369-81. PubMed ID: 3060557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mixed chimerism after allogeneic marrow transplantation.
    Frassoni F; Corvo R; Strada P; Sessarego M; Piaggio G; Figari O; Scarpati D; Bacigalupo A; Vitale V; Miceli S
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():241-3. PubMed ID: 2653512
    [No Abstract]   [Full Text] [Related]  

  • 6. The mechanism of recurrence of mouse myeloid leukaemia after total body irradiation and bone marrow transplantation.
    Poljak-Blazi M; Popović M; Majić T
    Oncology; 1994; 51(3):282-7. PubMed ID: 8196913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study on nonmyeloablative allogeneic bone marrow transplantation in the treatment of L615 leukemia mice].
    Xu KL; Ju JP; Pan XY; Du B; Li ZY; Lu QX
    Zhonghua Xue Ye Xue Za Zhi; 2003 Jul; 24(7):372-5. PubMed ID: 12941194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antileukemic effect of interleukin-2-transduced murine bone marrow after autologous transplantation.
    Tam YK; Klingemann HG
    Biol Blood Marrow Transplant; 1999; 5(4):231-42. PubMed ID: 10465103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression and elimination of BCL1 leukemia by allogeneic bone marrow transplantation.
    Weiss L; Morecki S; Vitetta ES; Slavin S
    J Immunol; 1983 May; 130(5):2452-5. PubMed ID: 6339628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone marrow transplantation: a review.
    Thomas ED
    Semin Hematol; 1999 Oct; 36(4 Suppl 7):95-103. PubMed ID: 10595758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone marrow transplantation from Fv-4-resistant donors rescues Friend leukemia virus-infected mice from leukemia: a model of bone marrow transplantation therapy against retroviral infection.
    Kitagawa M; Kamisaku H; Aizawa S; Sado T
    Leukemia; 1994 Dec; 8(12):2200-6. PubMed ID: 7808008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of dose rate and adriamycin on the tolerance of thoracic radiation in mice.
    Sherman DM; Carabell SC; Belli JA; Hellman S
    Int J Radiat Oncol Biol Phys; 1982 Jan; 8(1):45-51. PubMed ID: 7037706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of anti-CD3 epsilon F(ab')2 fragments in vivo to modulate graft-versus-host disease without loss of graft-versus-leukemia reactivity after MHC-matched bone marrow transplantation.
    Johnson BD; McCabe C; Hanke CA; Truitt RL
    J Immunol; 1995 May; 154(10):5542-54. PubMed ID: 7730653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiation dose-fractionation and dose-rate relationships for long-term repopulating hemopoietic stem cells in a murine bone marrow transplant model.
    van Os R; Thames HD; Konings AW; Down JD
    Radiat Res; 1993 Oct; 136(1):118-25. PubMed ID: 8210327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of cell-mediated IL-2-activated antitumor responses in conjunction with autologous and allogeneic bone marrow transplantation.
    Slavin S; Ackerstein A; Kedar E; Reich S; Gomez S; Naparstek E; Nagler A; Or R; Weiss L
    Transplant Proc; 1991 Feb; 23(1 Pt 1):802-3. PubMed ID: 1990696
    [No Abstract]   [Full Text] [Related]  

  • 16. Genetic analysis of the anti-leukemic effect of mixed allogeneic bone marrow transplantation.
    Sykes M; Sachs DH
    Transplant Proc; 1989 Feb; 21(1 Pt 3):3022-4. PubMed ID: 2650417
    [No Abstract]   [Full Text] [Related]  

  • 17. Optimal protocol for total body irradiation for allogeneic bone marrow transplantation in mice.
    Cui YZ; Hisha H; Yang GX; Fan TX; Jin T; Li Q; Lian Z; Ikehara S
    Bone Marrow Transplant; 2002 Dec; 30(12):843-9. PubMed ID: 12476275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful therapy of viral leukemia by transplantation of histocompatibly unmatched marrow.
    Meredith RF; Okunewick JP; Kuhnert PM; Brozovich BJ; Weaver EV
    Exp Hematol; 1978 Mar; 6(3):273-82. PubMed ID: 25780
    [No Abstract]   [Full Text] [Related]  

  • 19. History of bone marrow transplantation.
    Santos GW
    Clin Haematol; 1983 Oct; 12(3):611-39. PubMed ID: 6357577
    [No Abstract]   [Full Text] [Related]  

  • 20. Stages in the development of radiation-induced thymic lymphomas in C57 BL/Ka mice: preleukemic cells become progressively resistant to the tumor preventing effects of a bone marrow graft.
    Humblet C; Greimers R; Boniver J; Defrense MP
    Exp Hematol; 1997 Feb; 25(2):109-13. PubMed ID: 9015210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.